Recombinant CSF2 (Lenzilumab Biosimilar) antibody
The Human Monoclonal anti-CSF2 (Lenzilumab Biosimilar) antibody is suitable to detect CSF2 (Lenzilumab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.
Catalog No. ABIN7675954
$346.15
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant CSF2 (Lenzilumab Biosimilar) antibody (ABIN7675954)
Target
CSF2 (Lenzilumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CSF2 (Lenzilumab Biosimilar) antibody is un-conjugated
Application
Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-CSF2 / GM-CSF Reference Antibody (lenzilumab)
-
Characteristics
- Anti-CSF2 / GM-CSF Reference Antibody (lenzilumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- CSF2 (Lenzilumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P04141
Target
-
You are here:
